Emcure Pharmaceuticals (India) Analysis
| EMCURE Stock | 1,387 13.80 1.01% |
Emcure Pharmaceuticals is overvalued with Real Value of 1165.27 and Hype Value of 1382.89. The main objective of Emcure Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Emcure Pharmaceuticals is worth, separate from its market price. There are two main types of Emcure Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Emcure Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Emcure Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Emcure Pharmaceuticals stock is traded in India on National Stock Exchange of India, with the market opening at 09:15:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in India. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Emcure Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Emcure |
Emcure Stock Analysis Notes
About 87.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 26.38. Emcure Pharmaceuticals had not issued any dividends in recent years. To learn more about Emcure Pharmaceuticals call Satish Mehta at 91 20 3507 0033 or check out https://www.emcure.com.Emcure Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Emcure Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Emcure Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Emcure Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 87.0% of the company shares are held by company insiders |
Emcure Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 270.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Emcure Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Emcure Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Emcure Profitablity
Emcure Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Emcure Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Emcure Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Emcure Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Emcure Pharmaceuticals' profitability requires more research than a typical breakdown of Emcure Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13. Management Efficiency
Emcure Pharmaceuticals' management efficiency ratios could be used to measure how well Emcure Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.The strategic initiatives led by Emcure Pharmaceuticals' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Operating Margin 0.1337 | Profit Margin 0.074 |
Technical Drivers
As of the 22nd of December, Emcure Pharmaceuticals shows the Mean Deviation of 1.64, coefficient of variation of (20,136), and Standard Deviation of 2.33. Emcure Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Emcure Pharmaceuticals Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Emcure Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Emcure Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Emcure Pharmaceuticals Outstanding Bonds
Emcure Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Emcure Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Emcure bonds can be classified according to their maturity, which is the date when Emcure Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Emcure Pharmaceuticals Predictive Daily Indicators
Emcure Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Emcure Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Emcure Pharmaceuticals Forecast Models
Emcure Pharmaceuticals' time-series forecasting models are one of many Emcure Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Emcure Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Emcure Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Emcure Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Emcure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Emcure Pharmaceuticals. By using and applying Emcure Stock analysis, traders can create a robust methodology for identifying Emcure entry and exit points for their positions.
Emcure Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Emcure Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Complementary Tools for Emcure Stock analysis
When running Emcure Pharmaceuticals' price analysis, check to measure Emcure Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emcure Pharmaceuticals is operating at the current time. Most of Emcure Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Emcure Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emcure Pharmaceuticals' price. Additionally, you may evaluate how the addition of Emcure Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |